Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report)’s stock price gapped down before the market opened on Wednesday. The stock had previously closed at $118.12, but opened at $114.05. Pro Medicus shares last traded at $114.05, with a volume of 14 shares.
Wall Street Analysts Forecast Growth
Separately, Jefferies Financial Group lowered Pro Medicus from a “buy” rating to a “hold” rating in a research note on Wednesday, July 8th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Pro Medicus currently has a consensus rating of “Hold” and an average target price of $155.00.
Read Our Latest Report on Pro Medicus
Pro Medicus Trading Down 0.4%
Pro Medicus Company Profile
Pro Medicus Limited is an Australian medical technology company that develops software for medical imaging and healthcare organizations. Its primary product is the Visage enterprise imaging platform, which supports the storage, management, viewing and distribution of diagnostic images such as X-rays, CT scans and magnetic resonance images.
The company’s software is designed to help hospitals, radiology practices and other healthcare providers manage imaging workflows and enable clinicians to access diagnostic information across locations.
Read More
- Five stocks we like better than Pro Medicus
- McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier
- Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test
- 3 Emerging Biotech Stocks With Significant Upside Potential
- Treasury Yields Haven’t Been This High Since 2007—3 ETFs to Watch
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
